Home » Topics » Ear, nose and throat, BioWorld Science

Ear, nose and throat, BioWorld Science
RSS

New company Decibel Therapeutics launched to address hearing loss

Oct. 19, 2015

Otonomy receives IND application clearance for tinnitus candidate OTO-311

Oct. 7, 2015

Otologic licenses sensory hair cell regeneration technology from Hough Ear Institute

Oct. 2, 2015

Biophysical mechanisms causing susceptibility to tinnitus identified

Sep. 17, 2015

Gene therapy with viral vectors carrying Tmc genes, a promising approach for genetic deafness

July 28, 2015

Otonomy reveals topline data from phase IIb trial of OTO-104 in Meniere's disease

May 22, 2015

Otonomy completes enrollment in trial of AuriPro for otitis media with tympanostomy tubes

May 11, 2015

Interim analysis completed for phase III trial of AM-101 in post-acute tinnitus

March 11, 2015

Otonomy submits NDA to the FDA for AuriPro

March 2, 2015

Next Science wound gel inhibits biofilm development in ear infection models

Feb. 4, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
In 2025, science’s biggest story was political
BioWorld
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
FDA says yes to Cytokinetics’ aficamten, now Myqorzo, in oHCM
BioWorld
Cytokinetics Inc. scored U.S. FDA marketing clearance Dec. 19 for Myqorzo (aficamten) 5-mg, 10-mg, 15-mg, and 20-mg tablets to improve functional capacity and...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....